Clinical Trial

Endocrine Disruption, Menopause, and Poor Sleep in wOmen With Type 2 Diabetes: Effects on Cardiovascular Health

Name: Endocrine Disruption, Menopause, and Poor Sleep in wOmen With Type 2 Diabetes: Effects on Cardiovascular Health — clinical trial record (NCT07486986)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EMPOWER

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

EMPOWER aims to determine the overall effect of menopause and sleep disruption on cardiac remodeling in women with type 2 diabetes.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-17.

Trial Details

NCT Number	NCT07486986
Lead Sponsor	Ottawa Heart Institute Research Corporation
Conditions	Menopause, Sleep Disruption, T2DM
Enrollment	381 participants
Start Date	2026-09
Primary Completion	2032-12 (estimated)
Study Completion	2032-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-01